– Transformative Development and Co-Commercialization Collaboration with Chiesi – – Ongoing PROSERA Phase 3 Study in PAH Expected to Readout in Q4 2025 – – Registrational Phase 3 in PH-ILD Expected to Commence in Mid-2025 – – TORREY Phase 2 PAH Results Published in Lancet Respiratory Medicine – – Latest PAH Open-Label Extension Dataset to … [Read more…]

Positive efficacy and safety data of MaaT013 in aGvHD in the Early Access Program presented at the EBMT 2024 annual meeting with 63% GI-ORR at D28, a 49% one year and 42% 18 months Overall Survival (OS) in patients similar to those included in the ARES Phase 3 clinical trial. Primary endpoint readout, GI-ORR at … [Read more…]

Exhibition booth will provide research, clinical trial results, and supplement samples to conference attendees SAN FRANCISCO–(BUSINESS WIRE)–Defined Sleep, a pioneer in scientifically developed, supported, and validated CBD sleep supplements, is proud to announce its upcoming participation in the American Psychiatric Association (APA) 2024 Annual Meeting from May 4-8, 2024. This key event, held in New … [Read more…]

– On track to report topline data from pivotal Phase 3 SAPPHIRE trial in patients with Spinal Muscular Atrophy in 4Q 2024 – Initiating Phase 2 proof-of-concept trial evaluating apitegromab in obesity in June 2024 – Updated SRK-181 clinical data selected for oral presentation at American Society of Clinical Oncology (ASCO) – New SRK-439 preclinical … [Read more…]

Eight-color kit provides more usable information from degraded or inhibited DNA samples Includes all DNA markers recommended by the European Network of Forensic Science Institutes (ENFSI) Promega is the first manufacturer to produce eight-color chemistry for forensic DNA analysis MADISON, Wis.–(BUSINESS WIRE)–Forensic laboratories in Europe now have a new DNA analysis kit to efficiently process … [Read more…]

MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Tuesday, May 14, 2024, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first quarter of 2024. Participants during the … [Read more…]

An annual Experian Health survey shows a sharp reversal from last year with more satisfaction and perceptions that healthcare services have improved COSTA MESA, Calif.–(BUSINESS WIRE)–#digitalhealth–Healthcare providers and patients are in rare agreement that healthcare access and service-levels are improving, according to the Experian Health 2024 State of Patient Access survey. Almost a third (28%) … [Read more…]

THOUSAND OAKS, Calif–(BUSINESS WIRE)–Fertility & Surgical Associates of California (FSAC) is pleased to welcome Dr. Holly Mehr MD, MSEd, double board certified in Reproductive Endocrinology and Obstetrics and Gynecology, to our clinic. Dr. Mehr is now scheduling new patient appointments at our Santa Monica location. “I am excited to be joining the FSAC team. Every … [Read more…]

BOSTON–(BUSINESS WIRE)–Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that management will participate in a fireside chat at The Citizens JMP Life Sciences Conference on Monday, May 13, 2024 at 10:00 a.m. ET at the New York Hilton Midtown. A live audio webcast of Ironwood’s fireside chat will be accessible through the Investors section of the … [Read more…]

EL CAJON, Calif.–(BUSINESS WIRE)–PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported the appointment of Darin Zehr to its Board of Directors, effective as of May 1, 2024. Mr. Zehr joins as an independent director and will also serve as a member … [Read more…]